Rocky Mountain Regional Center of Excellence

RMRCE is a network of research collaborations that promotes the development of vaccines and therapies against infections caused by weapons of bioterrorism, and against emerging infectious disease.

The Rocky Mountain Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RMRCE) is one of 10 regional research consortia established by NIAID in response to the national threat posed by bioterrorism.

The RMRCE comprises 18 institutions in Colorado, Utah, Wyoming, Montana, North Dakota, and South Dakota that have combined resources to address the national need for an improved scientific infrastructure and development of novel diagnostic, therapeutic and vaccine countermeasures against Category A, B, and C pathogens.

Three scientific cores provide access to state-of-the-art proteomics, standardized small animal and aerosol models of disease transmission, and BSL3 laboratory facilities for translational development of vaccines and drugs leading to FDA approval. A wealth of scientific expertise on biothreat agents and contemporary biomedical technology is applied to establishing new products related to biodefense.

This network of interactive projects involves universities, federal and state agencies, and private corporations, and is coordinated through a central administrative core located at Colorado State University in Fort Collins, CO.